Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Vulcan Energy Resources Ltd.

Start price
Target price
Perf. (%)
€8.31
23.08.21
-
23.08.22
-31.84%
24.08.22

Probably not worthwhile Investment
buy
Nikola Corp.

Start price
Target price
Perf. (%)
€8.10
23.08.21
-
23.08.25
26.89%
28.09.21

Risky Investment
buy
Dongyue Group Ltd.

Start price
Target price
Perf. (%)
€2.40
23.08.21
-
23.08.22
-58.73%
24.08.22

Could be very worthwhile Investment >20% year
Medium risks for its business
Impel Neuropharma Inc.

Start price
Target price
Perf. (%)
€12.30
23.08.21
-
23.08.22
-40.24%
24.08.22

Probably not worthwhile Investment
Evotec SE

Start price
Target price
Perf. (%)
€42.98
23.08.21
-
23.08.22
-7.56%
11.10.21

Risky Investment
Aixtron SE

Start price
Target price
Perf. (%)
€23.04
23.08.21
-
23.08.22
-6.51%
11.10.21

Risky Investment
Siemens Healthineers AG

Start price
Target price
Perf. (%)
€60.10
23.08.21
-
23.08.22
-7.62%
11.10.21

Risky Investment
United Internet

Start price
Target price
Perf. (%)
€37.08
23.08.21
-
23.08.22
-6.77%
20.09.21

Risky Investment
1&1 Drillisch AG

Start price
Target price
Perf. (%)
€26.72
23.08.21
-
23.08.22
-6.66%
06.12.21

Risky Investment
buy
New Oriental Education & Technology Group

Start price
Target price
Perf. (%)
€1.60
22.08.21
-
22.08.22
16.79%
05.09.21

Risky Investment
buy
New Oriental Education & Technology Group ADR

Start price
Target price
Perf. (%)
€15.60
22.08.21
-
22.08.22
29.49%
05.09.21

Risky Investment
buy
51 Talk Online Education Group ADR

Start price
Target price
Perf. (%)
€7.12
22.08.21
-
22.08.22
62.92%
05.09.21

Risky Investment
buy
Gaotu Techedu Inc. ADR

Start price
Target price
Perf. (%)
€2.19
22.08.21
-
22.08.22
23.74%
05.09.21

Risky Investment
buy
TAL Education Group ADR

Start price
Target price
Perf. (%)
€4.68
22.08.21
-
22.08.22
-7.27%
05.09.21

Risky Investment
buy
Fortuna Silver Mines Inc.

Start price
Target price
Perf. (%)
€3.30
22.08.21
-
22.08.22
17.85%
05.09.21

Probably not worthwhile Investment
buy
MBB SE

Start price
Target price
Perf. (%)
€130.40
22.08.21
€149.00
22.08.22
3.37%
27.09.21

Standard Investments for future growth
Differentiated customer and product portfolio
Higher risks for its business
Significant cyclical dependencies
buy
Porsche Automobil Holding SE

Start price
Target price
Perf. (%)
€82.86
22.08.21
€95.00
22.08.22
3.11%
27.09.21

Fair valuation
Good rating
Differentiated customer and product portfolio
Higher risks for its business
buy
PNE AG

Start price
Target price
Perf. (%)
€7.39
22.08.21
€8.00
22.08.22
0.81%
04.09.21

Sustainability is important
Innovative
Future proof or reliable business model
Higher risks for its business
buy
Apple Inc.

Start price
Target price
Perf. (%)
€127.40
22.08.21
€150.00
31.03.23
4.71%
05.07.22

Revenue growth > 30% per year expected
Very positive Cash Flow expected
Top Rating
High Investments for future growth
Marathon Petroleum_INT

Start price
Target price
Perf. (%)
€47.00
21.08.21
-
21.08.22
19.49%
30.10.21

High dividend yield expected
Fair valuation
Capable Management
buy
Paycom Software

Start price
Target price
Perf. (%)
€400.30
21.08.21
€460.00
21.08.22
-6.26%
22.08.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Capable Management
Small cyclical dependencies
buy
Kohl's Corp.

Start price
Target price
Perf. (%)
€49.69
21.08.21
€50.00
21.08.22
3.40%
09.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Higher risks for its business
buy
Abiomed Inc.

Start price
Target price
Perf. (%)
€299.10
21.08.21
€325.00
21.08.22
-10.60%
22.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Future proof or reliable business model
buy
Cleveland-Cliffs Inc.

Start price
Target price
Perf. (%)
€19.84
21.08.21
€30.00
21.08.22
-15.89%
21.08.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Higher risks for its business
buy
Carisma Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.58
21.08.21
€220.00
21.08.22
-13.54%
08.01.22

Revenue growth >5% per year expected
Undervalued
Probably not worthwhile Investment
Lower EBIT Margin than peer group